Eli Lilly

Justin Hicks / IPB News

Indianapolis-based Eli Lilly is partnering with health care systems around the state to increase access and affordability around its COVID-19 antibody treatment. The company is working with the state of Indiana and health systems and has established three new infusion centers for its COVID-19 antibody therapy to treat those at high risk.

Lauren Chapman / IPB News

The political action committee of Indianapolis-based Eli Lilly, LillyPAC, has joined other major corporations in pausing political donations to some politicians after last week’s insurrection at the capitol. 

Lauren Chapman / IPB News

The Food and Drug Administration (FDA) has given emergency authorization to Eli Lilly for its COVID-19 antibody drug bamlanivimab.

Lauren Chapman / IPB News

Indianapolis-based Eli Lilly has ended testing its COVID-19 antibody therapy on hospitalized patients. Earlier this month, Eli Lilly temporarily suspended the trial for the drug due to a safety concern.

Study Pauses Are More Common, Essential To Clinical Trials

Oct 15, 2020
(Pixabay)

Eli Lilly paused trials of its COVID-19 treatment drug Tuesday. The news came less than a day after Johnson & Johnson also paused its trial on a COVID-19 vaccine.

(Courtesy of Johnson & Johnson)

Johnson & Johnson’s COVID-19 vaccine trial is now on hold, after a participant became ill. Though pauses are not uncommon throughout the study or trial process of new medication, the pressure and demand of developing a vaccine to fight COVID-19 has cast a spotlight on those pauses.

Lauren Chapman / IPB News

Indianapolis-based Eli Lilly has requested emergency use authorization (EUA), from the Food and Drug Administration (FDA), for it’s COVID-19 single antibody treatment.

Lauren Chapman / IPB News

Indianapolis-based Eli Lilly announced Wednesday its COVID-19 antibody drug is showing results in reducing hospitalizations from the virus. This is the company’s first data to be reported on mild to moderate cases but still needs to be reviewed by peers.

Lauren Chapman / IPB News

Indianapolis-based Eli Lilly is moving to Phase 3 testing of a treatment to prevent COVID-19 after initial success. The next step will be to test the drug at nursing homes where the pandemic has hit hard.

A third person in Indiana has died from the novel coronavirus – a second Marion County resident. 

The number of people being tested for the coronavirus has been limited by national shortages in tests and days-long waits for results. Two companies in Indiana are working to increase public testing.

Indianapolis-based Eli Lilly announced Friday its agreement to buy biopharmaceutical company Dermira.

Lilly will acquire the California-based company for a little more than $1 billion.

After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options. 

Prescription drug prices have continued to increase and the reasons are complicated.  A study committee examining causes of high drug costs heard about rebates, high deductible insurance plans and tiered drug systems as reasons why. 

Rule To Include Drugs Prices In Ads Challenged

Jun 19, 2019

Indianapolis-based Eli Lilly is challenging a new federal rule that would require drug companies to include prices in TV ads.

Reducing high drug prices is one of President Donald Trump’s priorities, and the move for more transparency through advertising was announced last year. 

Pages